TABLE 2.
Treatment-Resistant Depression |
||||||
---|---|---|---|---|---|---|
Medication Class | Unadjusted |
Model 1b |
Model 2c |
|||
Odds Ratio | 95% CI | Odds Ratio | 95% CI | Odds Ratio | 95% CI | |
Nonsteroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors and salicylatesd |
1.55 | 1.21–2.00 | 1.42 | 1.09–1.85 | 1.17 | 0.83–1.64 |
NSAIDs only | 1.74 | 1.40–2.18 | 1.56 | 1.23–1.97 | 1.31 | 1.03–1.76 |
COX-2 inhibitors only | 0.83 | 0.61–1.12 | 0.89 | 0.65–1.22 | 0.78 | 0.54–1.12 |
Salicylates only | 1.01 | 0.82–1.25 | 1.15 | 0.91–1.47 | 1.17 | 0.86–1.59 |
The reference group for these analyses is treatment responsive. Likelihood-ratio test compared the fit for model 2 > model 1 > unadjusted (p<0.001 for all comparisons).
The model 1 analysis included age, sex, race, and payer.
The model 2 analysis included model 1 variables as well as log-transformed fact count, age-adjusted Charlson comorbidity index, history of hypertension, history of hyperlipidemia, history of myocardial infarction, history of stroke, and history of type 2 diabetes.
Analysis is consistent with that of Warner-Schmidt et al. (3).